Literature DB >> 7889392

Early detection of ovarian cancer.

M G Teneriello1, R C Park.   

Abstract

Ovarian cancer meets the criteria of a disease for which screening can be justified. The disease is most often diagnosed in advanced stages, when chances for long-term survival are poor. Yet effective treatment exists for early-stage disease, such that early detection can increase long-term survival. However, screening for early-stage ovarian cancer with the high specificity necessary for this low-prevalence disease has proven to be a challenge. This article reviews the issues of early detection of ovarian cancer, including pathology, statistical considerations, diagnostic modalities, and results of the major clinical studies undertaken.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7889392     DOI: 10.3322/canjclin.45.2.71

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  7 in total

1.  Detection of ovarian cancer using plasma cell-free DNA methylomes.

Authors:  Huaiwu Lu; Yunyun Liu; Jingyu Wang; Shaliu Fu; Lingping Wang; Chunxian Huang; Jing Li; Lingling Xie; Dongyan Wang; Dan Li; Hui Zhou; Qunxian Rao
Journal:  Clin Epigenetics       Date:  2022-06-09       Impact factor: 7.259

2.  Family history in ovarian cancer referral population.

Authors:  L A Berg; S Robert Young; K A Brooks; A M Davis; S Terry Smith
Journal:  J Genet Couns       Date:  1996-03       Impact factor: 2.537

3.  Determination of serum CRP, VEGF, Leptin, CK-MB, CA-15-3 and IL-6 levels for malignancy prediction in adnexal masses.

Authors:  Serhat Sen; Oğuzhan Kuru; Ozgür Akbayır; Hilal Oğuz; Vildan Yasasever; Sinan Berkman
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

4.  Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.

Authors:  J Challberg; L Ashcroft; F Lalloo; B Eckersley; R Clayton; P Hopwood; P Selby; A Howell; D G Evans
Journal:  Br J Cancer       Date:  2011-06-07       Impact factor: 7.640

5.  Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.

Authors:  Lijun Fan; Mingzhu Yin; Chaofu Ke; Tingting Ge; Guangming Zhang; Wang Zhang; Xiaohua Zhou; Ge Lou; Kang Li
Journal:  J Cancer       Date:  2016-06-23       Impact factor: 4.207

6.  Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers.

Authors:  Eliane Duarte-Franco; Eduardo L Franco
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

7.  CA-125 and risk of malignancy index for screening for malignancy in fertile aged females with ovarian cyst, which is more cost effectiveness?

Authors:  Viroj Wiwanitkit
Journal:  Indian J Med Paediatr Oncol       Date:  2013-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.